Page last updated: 2024-10-16

gamma-aminobutyric acid and Glaucoma, Suspect

gamma-aminobutyric acid has been researched along with Glaucoma, Suspect in 1 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Research Excerpts

ExcerptRelevanceReference
" However, the neuroprotective effects and the mechanism of action of PNU-282987, an α7-nAChR agonist, in a chronic in vivo rat glaucoma model are poorly understood."3.85Alpha7 nicotinic acetylcholine receptor agonist promotes retinal ganglion cell function via modulating GABAergic presynaptic activity in a chronic glaucomatous model. ( Cheng, Y; Li, G; Wu, J; Yang, B; Zhang, R; Zhang, S; Zhou, X, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhou, X1
Cheng, Y1
Zhang, R1
Li, G1
Yang, B1
Zhang, S1
Wu, J1

Other Studies

1 other study available for gamma-aminobutyric acid and Glaucoma, Suspect

ArticleYear
Alpha7 nicotinic acetylcholine receptor agonist promotes retinal ganglion cell function via modulating GABAergic presynaptic activity in a chronic glaucomatous model.
    Scientific reports, 2017, 05-11, Volume: 7, Issue:1

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzamides; Bridged Bicyclo Compounds; Cell Surviv

2017